eli lilly drug cabinet by sciondriver (CC BY-NC-ND 2.0) https://flic.kr/p/cK3ExS

eli lilly drug cabinet by sciondriver (CC BY-NC-ND 2.0) https://flic.kr/p/cK3ExS


Why the Canadian Government Should Maintain Its Position on CETA and the ISDS Provision

Media reports last week indicated that finalizing the Canada – European Union Trade Agreement has been delayed by a Canadian demand to exclude intellectual property from the scope of the investor-state dispute settlement system. While that sounds like an arcane, technical issue, it actually involves potentially billions of dollars and the Canadian government deserves kudos for adopting its current position even as the pressure builds to simply cave on the issue.

The investor-state dispute settlement provision is among the most controversial aspects of CETA (and the proposed Trans Pacific Partnership) since it opens the door to private lawsuits by companies against the government over the state of national law. These lawsuits can involve claims for hundreds of millions of dollars, with costs that may ultimately be borne by taxpayers. The Canadian government is keenly aware of the risks, since it is currently facing a $500 million lawsuit by pharmaceutical giant Eli Lilly over the approach of Canadian courts to the concept of utility in patent law. The Canadian government is likely to ultimately win the lawsuit, but the legal risks are still significant, with Eli Lilly effectively demanding that every Canadian pay it nearly $15 due to our patent laws. If Eli Lilly can file a $500 million lawsuit over two patented drugs, the potential for numerous lawsuits and billions in claims is a real possibility.

With the government slowly realizing that ISDS provisions open the door to a flurry of similar lawsuits, it is now trying to slam it shut on European-based lawsuits by excluding intellectual property from the scope of the provision.  That is the right policy – the CATO Institute recently argued that ISDS provisions don’t belong in trade agreements altogether – and the Canadian government is taking the right position on CETA. ISDS provisions should be avoided and certainly should not extend to court rulings in intellectual property disputes. That is true for CETA and should also be the case for the Trans Pacific Partnership, which is still being negotiated.


  1. Angela Quinlan says:

    I am a member of GRAN, advocating for affordable medicines for Grandmothers and their orphans in sub Saharan Africa. CETA and TPP threaten to make generic medicine less available.

  2. Chris Brand says:

    What goes into these treaties has become ridiculous
    “Intellectual property” doesn’t belong in any “free trade” treaty (monopolies are the opposite of free trade).
    “ISDS” in CETA ? Because of course Europe and Canada have such archaic domestic legal systems and their governments go around expropriating private property all the time.
    And ISDS for IP in CETA ? Whoever even considered agreeing to that should lose their job.

  3. TILMA
    ISDS is in TILMA (2006), between BC and Alberta. TILMA was foisted upon us to address non-existent trade barriers between the provinces. We were told TILMA would result in 78,000 new jobs. Which was lie number two. Lie number three was a claim of $4.8 billion in GDP benefits. Which reminds me of the ridiculous benefits claimed for CETA.

  4. طراحی سایت says:

    طراحی سایت
    Great post.This article is very helpful. keep sharing such information

  5. طراحی سایت says:

    طراحی سایت
    Great post.This article is very helpful. keep sharing such information

  6. Pingback: the $500 million tip of the TPP iceberg | Fair Duty